Janeen Noel Doyle

CHIEF CORP. & BUS. DEV. OFCR · JANUX THERAPEUTICS, INC. · CIK 0002069239

FILING MIX · LIFETIME80%/20%

BUYS

SELLS

TOTAL VALUE

$56.9K

COMPANIES

ACTIVE SINCE

Jun 2025

HOLDINGS NOW

75,941

AVG SELL PX

$14.03

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for Janeen Noel Doyle. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

JANX · 75,941 shares · as of Jun 2, 2026

Trading cadence · quarterly flow

BUY ● SELL ●

2025

2026

FLOW · 4 buys / 1 sellsCOVERAGE · 5 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
JANX JANUX THERAPEUTICS, INC.	SALE Chief Corp. & Bus. Dev. Ofcr	4,059	$14.03	$56.9K	75,941	Jun 2, 2026	Jun 4, 2026 ↗	View →
JANX JANUX THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	126,000	—	—	126,000	Jan 2, 2026	Jan 2, 2026 ↗	View →
JANX JANUX THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	36,000	—	—	80,000	Jan 2, 2026	Jan 2, 2026 ↗	View →
JANX JANUX THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	44,000	—	—	44,000	Jun 2, 2025	Jun 4, 2025 ↗	View →
JANX JANUX THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	154,000	—	—	154,000	Jun 2, 2025	Jun 4, 2025 ↗	View →

Other insiders · JANX

Loading peer insiders…

About this filer

CIK 0002069239

ROLE

Chief Corp. & Bus. Dev. Ofcr

PRIMARY

JANX

COMPANIES

ACTIVE SINCE

Jun 2025

MARKETPEEL · /INSIDER/0002069239DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

The morning brief, before the bell.